Virtus Biotech Clinical Trials ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBC and other ETFs, options, and stocks.

About BBC

BBC tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. 

Index-Tracked
FT Wilshire 5000 TR USD
Index-TrackedFT Wilshire 5000 TR USD
Category
Health
CategoryHealth
Number of holdings
132
Number of holdings132
Inception Date
Dec 16, 2014
Inception DateDec 16, 2014

BBC Key Statistics

AUM
43.12M
AUM43.12M
Price-Earnings ratio
-7.06
Price-Earnings ratio-7.06
30-Day yield
30-Day yield
Average volume
20.48K
Average volume20.48K
High today
$49.49
High today$49.49
Low today
$48.14
Low today$48.14
Open price
$48.16
Open price$48.16
Volume
37.84K
Volume37.84K
52 Week high
$49.49
52 Week high$49.49
52 Week low
$18.77
52 Week low$18.77
Expense ratio
0.65
Expense ratio0.65

Stock Snapshot

As of today, Virtus Biotech Clinical Trials ETF(BBC) shares are valued at $49.49. The company's market cap stands at 46.11M, with a P/E ratio of -7.06.

During the trading session on 2026-06-23, Virtus Biotech Clinical Trials ETF(BBC) shares reached a daily high of $49.49 and a low of $48.14. At a current price of $49.49, the stock is +2.8% higher than the low and still 0.0% under the high.

Trading volume for Virtus Biotech Clinical Trials ETF(BBC) stock has reached 37.84K, versus its average volume of 20.48K.

The stock's 52-week range extends from a low of $18.77 to a high of $49.49.

The stock's 52-week range extends from a low of $18.77 to a high of $49.49.

Average Annual Return

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.